Abstract
Nitric oxide (NO) is produced by many cells within the respiratory tract and endogenous NO may play an important signalling role in the physiological control of airway function and in the pathophysiology of airway diseases [1–3]. All three isoforms of NO synthase (NOS) exist within the respiratory tract [4–6]. The endothelial constitutive isoform (eNOS) is localised to bronchial endothelial cells and to epithelial cells [7] and the neuronal isoform (nNOS) to parasympathetic nerves and to epithelial cells [8, 9]. Inducible NOS (iNOS) may be localised to several cell types, including epithelial cells and macrophages [10–12] and may be expressed even in the normal human respiratory tract (Fig. 1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barnes PJ, Belvisi MG (1993) Nitric oxide and lung disease. Thorax 48: 1034–1043
Gaston B, Drazen JM, Loscalzo J, Stamler JS (1994) The biology of nitrogen oxides in the airways. Am J Re.spir Crit Care Med 149: 538–551
Barnes PJ, Liew FY (1995) Nitric oxide and asthmatic inflammation. Immunol Today 16: 128–130
Kobzik L, Bredt DS, Lowenstein CJ, Drazen J, Gaston D, Sugarbaker D et al (1993) Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Resp Cell Mol Biol 9: 371–377
Furukawa K, Harrison DG, Saleh D, Shennib H, Chagnon FP, Giaid A (1996) Expression of nitric oxide synthase in human nasal mucosa. Am J Respir Crit Care Med 153: 847–850
Tracey WR, Xue C, Klinghoffer V, Barlow J, Pollock JS, Forstermann U et al (1994) Immunocytochemical detection of inducible NO synthase in human lung. Am J Physiol 266: L722–727
Shaul PW, North AJ, Wu LC, Wells LB, Brannon TS, Lau KS et al (1994) Endothelial nitric oxide synthase is expressed in cultured bronchiolar epithelium. J Clin Invest 94: 2231–2236
Ward JK, barnes PJ, Springall DR, Abelli L, Tadjkarimi S, Yacoub MH et al (1995) Human iNANC bronchodilatation and nitric oxide-immunoreactive nerves are reduced in distal airways. Am J Resp Cell Mol Biol 13: 175–184
Asano K, Chee CBE, Gaston B, Lilly CM, Gerard C, Drazen JM et al (1994) Constitutive and inducible nitric oxide synthase gene expression, regulation and activity in human lung epithelial cells. Proc Nail Acad Sci USA 91: 10089–10093
Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A et al (1993) Induction of nitric oxide synthase in asthma. Lancet 342: 1510–1513
Guo FH, de Raeve HR, Rice TW, Stuehr DJ, Thunnissen FBJM, Erzurum SC (1995) Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Nati Acad Sci USA 92: 7809–7813
Lundberg JON, Farkas-Szallasi T, Weitzberg E, Rinder J, Lidholm J, Anggard A et al (1995) High nitric oxide production in human paranasal sinuses. Nature Med 1: 370–373
Gustaffsson LE, Leone AM, Persson M, Wiklund NP, Moncada S (1991) Endogenous nitric oxide is present in the exhaled air of rabbits, guinea-pigs and humans. Biochem Biophys Res Commun 181: 852–857
Borland C, Cox Y, Higenbottam T (1993) Measurement of exhaled nitric oxide in man. Thorax 48: 1160–1162
Alving K, Weitzberg E, Lundberg JM (1993) Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6: 1268–1270
Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne E, Barnes PJ (1994) Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343: 133–135
Persson MG, Wiklund NP, Gustafsson LE (1993) Endogenous nitric oxide in single exhalation, and the change during exercise. Am Rev Respir Dis 148: 1210–1214
Persson MG, Midtvedt T, Leone AM, Gustafsson LE (1994) Ca2+-dependent and Ca2+-independent exhaled nitric oxide, presence in germ-free animals and inhibition by arginine analogues. Eur J Pharmacol 264: 13–20
Leone AM, Gustafsson LE, Francis PL, Persson MG, Wiklund NP, Moncada S (1994) Nitric oxide in exhaled breath in humans: direct GC-MS confirmation. Biochem Biophys Res Commun 201: 883–887
Robbins RA, Floreani AA, Von Essen SG, Sisson JH, Hill GE, Rubinstein I et al (1996) Measurement of nitric oxide by three different techniques. Am JRespir Crit Care Med 153: 1631–1635
Persson MG, Zetterstrom 0, Argenius V, Ihre E, Gustafsson LE (1994) Single-breath oxide measurements in asthmatic patients and smokers. Lancet 343: 146–147
Kharitonov SA, Wells AU, O’Connor BJ, Cole PJ, Hansell DM, Logan-Sinclair RB, Barnes PJ (1995) Elevated levels of exhaled nitric oxide in bronchiectasis. Am JResp Crit Care Med 151: 1889–1893
Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ (1995) Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Resp Crit Care Med 152: 892–896
Kharitonov SA, Yates DH, Barnes PJ (1996) Regular inhaled budesonide decreases nitric oxide concentration in the exhaled air of asthmatic patients. Am JResp Crit Care Med 153: 454–457
Barnes PJ, Kharitonov SA (1996) Exhaled nitric oxide: a new lung function test. Thorax 51: 218–220
Archer S (1993) Measurement of nitric oxide in biological models. FASEB J 7: 349–360
Kharitonov SA, Barnes PJ (1997) There is no nasal contribution to exhaled NO during exhalation against resistance or during breath-holding. Am J Respir Crit Care Med 155: A824
Gerlach H, Rossaint R, Pappert D, Knorr M, Falke KJ (1994) Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 343: 518–519
Lundberg JON, Weitzberg E, Nordvall SL, Kuylenstierna R, Lundberg JM, Alving K (1994) Primarily nasal origin of exhaled nitric oxide and absence in Kartagener’s syndrome. Eur Resp J 8: 1501–1504
Kimberley B, Nejadnik B, Giraud GD, Holden WE (1996) Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. Am J Respir Crit Care Med 153: 829–836
Kharitonov S, Chung KF, Evans DJ, O’Connor BJ, Barnes PJ (1996) Increased exhaled nitric oxide in asthma is derived from the lower respiratory tract. Am JRespir Crit Care Med 153: 1773–1780
Sato K, Sakamaki T, Sumino H, Sakamoto H, Hoshino J, Masuda H et al (1996) Rate of nitric oxide release in the lung and factors influencing the concentration of exhaled nitric oxide. Am J Physiol 14: L914–L920
Kharitonov SA, Yates D, Barnes PJ (1995) Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Resp J 8: 295–297
Kharitonov SA, Lubec G, Lubec B, Hjelm M, Barnes PJ (1995) L-Arginine increase exhaled nitric oxide in normal human subjects. Clin Sci 88: 135–139
Massaro AF, Drazen JM (1996) Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow. J Appl Physiol 80: 1863–1864
Schilling J, Holzer P, Guggenbach M, Gyurech D, Marathia K, Geroulanos S (1994) Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensioners. Eur Resp J 7: 467–471
Kharitonov SA, Robbins RA, Yates D, Keatings V, Barnes PJ (1995) Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Resp Crit Care Med 152: 609–612
Buga GM, Griscavage JM, Rogers NE, Ignarro LJ (1993) Negative feedback regulations of endothelial cell function by nitric oxide. Circ Res 73: 808–812
Assrevy J, Cunha FQ, Liew FY, Moncada S (1993) Feedback inhibition of nitric oxide synthase by nitric oxide. Br J Pharmacol 108: 833–837
Rengasamy A, Johns RA (1993) Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 44: 124–128
Jain B, Lubinstein I, Robbins RA, Leise KL, Sisson JH (1993) Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun 191: 83–88
Yates DH, Kharitonov SA, Barnes PJ (1996) The effect of alcohol ingestion on exhaled nitric oxide. Eur Respir J 9: 1130–1133
Xie J, Kolls J, Bagby G, Greenberg SS (1995) Independent suppression of nitric oxide and TNF-a in the lung of conscious rata by ethanol. FASEB J 9: 253–261
Cremona G, Higenbottam J, Takao M, Hall L, Bower EA (1995) Exhaled nitric oxide in isolated pig lungs. J Appl Physiol 78: 59–63
Belvisi MG, Barnes PJ, Larkin S, Yacoub MH, Tadjkarimi S, Williams T et al (1995) Nitric oxide synthase activity is elevated in inflammatory lung diseases in humans. Eur J Pharmacol 283: 252–258
Robbins RA, Springall DR, Warren JB, Kwon OJ, Buttery LKD, Wilson AJ et al (1994) Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 198: 1027–1033
Robbins RA, Barnes PJ, Springall DR, Warren JB, Kwon OJ, Buttery LKD et al (1994) Expression of inducible nitric oxide synthase in human bronchial epithelial cells. Biochem Biophys Res Commun 203: 209–218
Springall DR, Meng Q, Redington A, Howarth PH, Evans TJ, Polak JM (1995) Inducible nitric oxide synthase in asthmatic airway epithelium is reduced by corticosteroid therapy. Am J Re.spir Crit Care Med 151: A833
Du Bois AB, Douglas JS, Leaderer BP, Mohsenin V (1994) The presence of nitric oxide in the nasal cavity of normal humans. Am J Respir Crit Care Med 149: A197
Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM (1996) Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 153: 1510–1514
Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D et al (1993) Endogenous nitric oxides and bronchodilator S-nitrosolthiols in human airways. Proc Natl Acad Sci USA 90: 10957–10961
Barnes PJ, Liew FY (1995) Nitric oxide and asthmatic inflammation. Immunology Today 16: 128–130
Liew FY, Cox FF (1991) Nonspecific resistance mechanisms: the role of nitric oxide. Immunology Today 12: A17–A21
Wei X, Charles IG, Smith A, Ure J, Feng GJ, Huang FP et al (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408–411
Laubach VE, Shesely EG, Smithies 0, Sherman PA (1995) Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide induced death. Proc Natl Acad Sci USA 92: 10688–10692
Higenbottam TW (1995) Lung disease and pulmonary endothelial nitric oxide. Exp Physiol 134: 855–864
Crawley DF, Liu SF, Evans TW, Barnes PJ (1990) Inhibitory role of endothelium-derived nitric oxide in rat and human pulmonary arteries. Br J Pharmacol 101: 166–170
Liu SF, Crawley DE, Barnes PJ, Evans TW (1991) Endothelium derived nitric oxide inhibits pulmonary vasoconstriction in isolated blood perfused rat lungs. Am Rev Respir Dis 143: 32–37
Martinez C, Cases E, Vila JM, Aldasoro M, Medina P, Marco V et al (1995) Influence of endothelial nitric oxide on neurogenic contraction of human pulmonary arteries. Eur Respir J 8: 1328–1332
Belvisi MG, Stretton CD, Yacoub MH, Barnes PJ (1992) Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways. Eur J Pharmacol 210: 221–222
Ward JK, Belvisi MG, Fox AJ, Miura M, Tadjkarimi S, Yacoub MH et al (1993) Modulation of cholinergic neural bronchoconstriction by endogenous nitric oxide and vasoactive intestinal peptide in human airways in vitro. J Clin Invest 92: 736–743
Hogman M, Frostell CG, Hedenstrom H, Hedenstiema G (1993) Inhalation of nitric oxide modulates adult human bronchial tone. Am Rev Respir Dis 148: 1474–1478
Sanna A, Kurtansky A, Veriter C, Stanescu D (1994) Bronchodilator effect of inhaled nitric oxide in healthy men. Am JRespir Crit Care Med 150: 1702–1709
Kacmarek RM, Ripple R, Cockrill BA, Bloch KJ, Zapol WM, Johnson DC (1996) Inhaled nitric oxide: a bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am JRespir Crit Care Med 153: 128–135
Yates DH, Kharitonov SA, Thomas PS, Barnes PJ (1996) Endogenous nitric oxide is decreased after inhalation of a specific inhibitor of inducible nitric oxide synthase in asthmatic but not in normal subjects. Am JRespir Crit Care Med 151: A699
Robbins RA, Floreani AA, Von Essen SG, Sisson JH, Hill GE, Rubinstein I et al (1996) Measurement of exhaled nitric oxide by three different techniques. Am J Respir Crit Care Med 153: 1631–1635
Kharitonov SA, O’Connor BJ, Evans DJ, Barnes PJ (1995) Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Resp Crit Care Med 151: 1894–1899
Gamier P, Fajac I, Dessanges JF, Dall’Ava-Santucci J, Lockhart A, Dinh-Xuan AT (1996) Exhaled nitric oxide during acute changes in airways calibre in asthma. Eur Respir J 9: 1134–1138
Yates DH, Kharitonov SA, Scott DM, Worsdell M, Barnes PJ (1995) Short and long acting b2-agonists do no alter exhaled nitric oxide in asthma. Am JRespir Crit Care Med 151: Al29
Endo T, Uchida Y, Nomura A, Ninomiya H, Sakamoto T, Hasegawa S (1995) Inccreased production of nitric oxide in the immediate and late response models of guinea-pig experimental asthma. Am JRespir Crit Care Med 151: A177
Massaro AF, Gaston B, Kita D, Fanta C, Stamler J, Drazen JM (1995) Expired nitric oxide levels during treatment of acute asthma. Am JRespir Crit Care Med 152: 800–803
Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ (1994) Endogenous nitric oxide is increased in the exhaled air of asthmatic patients. Am J Respir Crit Care Med 149: A198
Kharitonov SA, Yates DH, Chung KF, Barnes PJ (1996) Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur J Respir Dis 9: 196–201
Kharitonov SA, Evans DJ, Barnes PJ, O’Connor BJ (1995) Bronchial provocation challenge with histamine or adenosine 5’ monophosphate does not alter exhaled nitric oxide in asthma. Am JRespir Crit Care Med 151: Al25
Lundberg JON, Nordvall SL, Weitzberg E, Kollberg H, Alving K (1996) Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child 75: 323–326
Balfour-Lynn IM, Laverty A, Dinwiddic R (1996) Reduced upper airway nitric oxide in cytic fibrosis. Arch Dis Child 75: 319–322
Thomas SR, Kharitonov SA, Hodson ME, Barnes PJ (1997) Exhaled and nasal nitric oxide levels are reduced in patients with cystic fibrosis. Am J Respir Crit Care Med 155: A198
Keatings VM, Collins PD, Scott DM, Barnes PJ (1996) Differences in interleukin-8 and tumor necrosis factor-a in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am JRespir Crit Care Med 153: 530–534
Rutgers SR, Postma DS, Van der Mark TW, Koeter GH (1996) Nitric oxide in exhaled air in COPD. Eur Respir J 9 (Suppl 23): 13S
Cailes JB, Kharitonov S, Yates D, Barnes P, DuBois RM (1995) Decreased endogenous nitric oxide in the exhaled air of systemic sclerosis patients. Thorax 50: 452P
Giaid A, Saleh D (1995) Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. New Engl J Med 333: 214–221
Barnes PJ, Liu S (1995) Regulation of pulmonary vascular tone. Physiol Rev 47: 87–118
Liu S, Adcock IM, Old RW, Barnes PJ, Evans TW (1993) Lipopolysacharide treatment in vivo induces widespread expression of inducible nitric oxide synthase mRNA. Biochem Biophys Res Commun 196: 1208–1213
Kharitonov SA, Nightingale JA, Chung KF, Barnes PJ (1997) Inhaled bacterial lipopolysaccharide increases exhaled nitric oxide in normal and asthmatic subjects. Am J Respir Crit Care Med 155: A946
Heiss LN, Lancaster JR, Corbett JA, Goldman WE (1994) Epithelial autotoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Nail Acad Sci USA 91: 267–270
Vosswinkel R, Neidt I, Bothe H (1991) The production and utilization of nitric oxide by a new denitrifying strain of Pseudomonas aeuruginosa. Arch Microbiol 156: 62–69
Cannons AC, Barber MJ, Solomonson LP (1993) Expression and characterization of the home-binding domain of Chlorella nitrate reductase. J Biol Chem 268: 3268–3271
Martin U, Bryden K, Devoy M, Howarth PH (1996) Increased levels of exhaled nitric oxide during nasal or oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol 97: 768–772
Kharitonov SA, Rajakulasingam K, O’Connor BJ, Durham SR, Barnes PJ (1997) Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 99: 58–64
Garrelds IM, van Amsterdam JGC, de Graaf-In’t Veld C, van Wijk G, Zijlstra MN (1995) Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy. Thorax 50: 275–279
Laitinen LA, Laitinen A, Haahtela T (1992) A comparative study of the effects of an inhaled corticosteroid, budesonide, and of a /32agonist, terbutaline, on airway inflammation in newly diagnosed asthma. J Allergy Clin Immunol 90: 32–42
Gardiner PV, Ward C, Booth H, Allison A, Hendrick DJ, Walters EH (1994) Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Resp Crit Care Med 150: 1006–1011
Yates DH, Kharitonov SA, Worsdell M, Thomas PS, Barnes PJ (1995) Exhaled nitric oxide is decreased after inhalation of a specific inhibitor of inducible nitric oxide synthase, in asthmatic but not in normal subjects. Am J Resp Crit Care Med 152: 892–896
Haynes WG, Noon JP, Walker BR, Webb DJ (1993) Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertension 11: 1375–1380
Stammler JS, Loh E, Roddy M, Currie XE, Creager MA (1994) Nitric oxide regulates broad systemic and pulmonary vascular resistance in normal humans. Circulation 89: 2035–2040
Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG et al (1993) Selective inhibition of inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233: 119–125
Hasan K, Heesen BJ, Corbett JA, McDaniel ML, Chang K, Allison W et al (1993) Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249: 101–106
Jatakanon A, Lim S, Chung KF, Barnes PJ (1997) Correlation between exhaled nitric oxide, sputum eosinophils and methacholine responsiveness. Am J Respir Crit Care Med 155: 819
Kharitonov SA, Jatakanon A, Lim S, O’Connor BJ, Barnes PJ (1997) Dose-dependent reduction in exhaled nitric oxide in patients with asthma regularly treated with 100 mg, 400 mg budesonide in double-blind placebo-controlled parallel group study. Am J Respir Crit Care Med 155: A290
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Barnes, P.J., Kharitonov, S.A. (2000). Nitric Oxide in Exhaled Air: Relevance in Inflammatory Lung Disease. In: Belvisi, M.G., Mitchell, J.A. (eds) Nitric Oxide in Pulmonary Processes. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8474-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8474-7_9
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9582-8
Online ISBN: 978-3-0348-8474-7
eBook Packages: Springer Book Archive